Newtyn Management’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22,443
| Closed | -$458K | – | 48 |
|
|
2023
Q4 | $458K | Sell |
22,443
-2,557
| -10% | -$52.2K | 0.09% | 44 |
|
|
2023
Q3 | $603K | Sell |
25,000
-1,100
| -4% | -$26.5K | 0.15% | 41 |
|
|
2023
Q2 | $636K | Sell |
26,100
-17,214
| -40% | -$419K | 0.15% | 39 |
|
|
2023
Q1 | $1.03M | Sell |
43,314
-1,543
| -3% | -$36.8K | 0.2% | 56 |
|
|
2022
Q4 | $1.27M | Buy |
44,857
+3,190
| +8% | +$90.3K | 0.26% | 48 |
|
|
2022
Q3 | $1.03M | Buy |
+41,667
| New | +$1.03M | 0.23% | 54 |
|